| Term 
 | Definition 
 
        | Albumarc Albutein Flexbumin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Colloid Blood modifier agent Volume expander |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oncotically similar to plasma Causes the body to shift approximately 3.5 times the amount administered into the intravascular space |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hypersensitivity Patients at risk for hypervolemia |  | 
        |  | 
        
        | Term 
 
        | Adverse reactions/Side effects |  | Definition 
 
        | Possible urticaria (hives) from hypersensitivity Use caution in patients with renal insufficiency or anemia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | None currently identified |  | 
        |  | 
        
        | Term 
 
        | Dosage and administration |  | Definition 
 
        | Adult: 12.5 to 25 g via I.V.   Pediatric: 0.5 to 1 g/kg via I.V. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Onset: 15 to 30 minutes   Peak: Unknown   Duration: 24 hours |  | 
        |  |